Summit Therapeutics Inc.

Company: Summit Therapeutics Inc.

Deadline: TBD

Kaskela Law LLC is investigating Summit Therapeutics Inc. (“Summit”) (NASDAQ: SMMT) on behalf of the company’s shareholders.

The investigation seeks to determine whether Summit and/or the company’s officers and directors have violated the securities laws in connection with recent corporate actions.

Summit shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by completing the information form on this page, for additional information about this investigation and their legal rights and options.

Submit Your Information

  • Date Format: MM slash DD slash YYYY
  • This field is for validation purposes and should be left unchanged.